Gerresheimer To replace Schwarz Pharma In SDAX - Unscheduled Adjustments In Equity Index Effective On September 6

With effect from September 6, Gerresheimer will be included in the SDAX® index as part of an unscheduled amendment to its composition, replacing Schwarz Pharma. <

Schwarz Pharma will leave the Prime Standard, its shares therefore no longer meet the requirements for SDAX inclusion.

The next regular review of the equity indices of Deutsche Börse is scheduled for September 5, 2007.